Medical Weight Loss for Vineland, New Jersey Residents
Vineland, New Jersey residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Vineland through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Vineland Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Vineland, New Jersey residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Vineland is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.
Patients across Vineland and the surrounding area connect with Dr. Sharma by secure video, wherever they live in New Jersey. We care for patients throughout downtown Vineland and the greater Cumberland County area of South Jersey. Every prescription for Vineland is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Telehealth removes the distance between Vineland and specialized care: your consultation happens wherever you are in New Jersey. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Vineland patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Vineland
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Vineland
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Vineland address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Vineland
How do I get treatment from Vineland?
As a Vineland, New Jersey patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Vineland?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Vineland in cold-pack packaging, no lines and no drive.
How much does it cost for Vineland patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Vineland do you serve?
We serve patients from across Vineland by telehealth, including downtown Vineland and the greater Cumberland County area of South Jersey.
How does compounded medication compare on cost for Vineland patients?
Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Vineland patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Vineland, New Jersey by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.